Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 545.74 Million CNY | -3.97% |
| 2022 | 502.23 Million CNY | 32.63% |
| 2021 | 378.66 Million CNY | 110.55% |
| 2020 | 179.85 Million CNY | 60.78% |
| 2019 | 111.86 Million CNY | 48.73% |
| 2018 | 75.21 Million CNY | 161.53% |
| 2017 | 28.76 Million CNY | 14.72% |
| 2016 | 25.06 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 14.97 Million USD | 0.0% |
| 2024 Q1 | 15.06 Million USD | -58.84% |
| 2023 FY | 482.3 Million CNY | -3.97% |
| 2023 Q1 | 21.44 Million USD | -51.13% |
| 2023 Q2 | 40.55 Million USD | 89.09% |
| 2023 Q3 | 24.01 Million USD | -40.79% |
| 2023 Q4 | 36.6 Million USD | 52.46% |
| 2022 FY | 502.23 Million CNY | 32.63% |
| 2022 Q4 | 43.88 Million USD | -20.1% |
| 2022 Q3 | 54.92 Million USD | 46.2% |
| 2022 Q2 | 37.56 Million USD | 0.0% |
| 2021 Q4 | 37.49 Million USD | 0.0% |
| 2021 FY | 378.66 Million CNY | 110.55% |
| 2021 Q2 | 26.64 Million USD | 0.0% |
| 2020 Q2 | 8.79 Million USD | 0.0% |
| 2020 Q4 | 19.26 Million USD | 0.0% |
| 2020 FY | 179.85 Million CNY | 60.78% |
| 2019 Q2 | 6.08 Million USD | 0.0% |
| 2019 Q4 | 8.63 Million USD | 0.0% |
| 2019 FY | 111.86 Million CNY | 48.73% |
| 2018 FY | 75.21 Million CNY | 161.53% |
| 2017 FY | 28.76 Million CNY | 14.72% |
| 2016 FY | 25.06 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 10.86 Million USD | -4922.076% |
| Skye Bioscience, Inc. | 13.54 Million USD | -3928.396% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -1364.875% |
| Nascent Biotech, Inc. | 2.22 Million USD | -24374.377% |
| Qrons Inc. | 643.67 Thousand USD | -84686.158% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 22.97 Million USD | -2275.424% |
| CSL Limited | 3.44 Billion USD | 84.177% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -1746.679% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -10723.963% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -58995.083% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -850.12% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -131254.172% |
| Rebus Holdings, Inc. | 664 Thousand USD | -82091.114% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -40766.881% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -139991.538% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -3308.75% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -528.852% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -10997.167% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -208419.215% |
| SQZ Biotechnologies Company | 85.61 Million USD | -537.416% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -18614.164% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -36237.264% |
| Mesoblast Limited | 5.9 Million USD | -9146.849% |
| Marizyme, Inc. | 19.23 Million USD | -2736.558% |
| Genus plc | 147.7 Million USD | -269.498% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -6116.362% |
| Pharming Group N.V. | 225.49 Million USD | -142.027% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -26538.73% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -40580.633% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -6444.538% |
| ContraFect Corporation | 56.88 Million USD | -859.323% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -12278.989% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -36806.053% |
| IMV Inc. | 37.7 Million USD | -1347.256% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -19458.393% |
| MultiCell Technologies, Inc. | 567.42 USD | -96180683.194% |
| ONE Bio Corp. | 6.44 Million USD | -8369.245% |
| Accustem Sciences Inc. | 3.74 Million USD | -14467.217% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -534.998% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -102491.726% |
| Q BioMed Inc. | 3.43 Million USD | -15780.363% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -2108.169% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -20670.483% |
| Biomind Labs Inc. | 994.18 Thousand USD | -54794.275% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -449.429% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -30914.14% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -8023.665% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -29172.569% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 2183096.0% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -29639.55% |
| GB Sciences, Inc. | 1.42 Million USD | -38319.257% |
| Alpha Cognition Inc. | 9.7 Million USD | -5523.031% |
| HST Global, Inc. | 140.9 Thousand USD | -387211.489% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -48414.903% |
| Halberd Corporation | 74.84 Thousand USD | -729101.518% |
| Enzolytics Inc. | 2.17 Million USD | -24940.021% |
| Agentix Corp. | 1.37 Million USD | -39684.699% |
| Resverlogix Corp. | 12.71 Million USD | -4193.18% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -14849.132% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 64.412% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -52174.808% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -22592.889% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -34455.182% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -15927.97% |
| AVAX Technologies, Inc. | 7.31 Million USD | -7365.517% |
| Zenith Capital Corp. | 8.94 Million USD | -6002.527% |
| Genscript Biotech Corporation | 825.34 Million USD | 33.876% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -3132607.652% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -22127.232% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -318104.292% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -28311.021% |
| Kadimastem Ltd | 2.41 Million USD | -22544.134% |
| Helix BioMedix, Inc. | 1.97 Million USD | -27574.421% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -300613.007% |
| LadRx Corporation | 3.81 Million USD | -14217.39% |
| Cell Source, Inc. | 4.32 Million USD | -12517.465% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -58995.083% |
| NovAccess Global Inc. | 2.46 Million USD | -22024.113% |
| Affymax, Inc. | 39.38 Million USD | -1285.642% |
| Itoco Inc. | 919.14 Thousand USD | -59275.853% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -12776.255% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -48671.135% |
| Mobile Lads Corp. | 554.54 Thousand USD | -98313.657% |
| CytoDyn Inc. | 18.05 Million USD | -2922.201% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -2168238.035% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -247879.807% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -38338.659% |
| SYBLEU INC | 160.87 Thousand USD | -339135.809% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -29946.963% |
| International Stem Cell Corporation | 5.27 Million USD | -10253.804% |
| Bioxytran, Inc. | 3.82 Million USD | -14186.073% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -1036617.83% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -2682636.076% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -1404.85% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -33629.852% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -74067.307% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -17442.559% |
| Neutra Corp. | 243.82 Thousand USD | -223731.827% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -3026.247% |
| PureTech Health plc | 144.59 Million USD | -277.428% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -2563.504% |
| IXICO plc | 4.7 Million USD | -11494.413% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -6103.808% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -363.489% |
| CSL Limited | 3.89 Billion USD | 85.981% |
| Cellectis S.A. | 97.32 Million USD | -460.778% |